Olivier Léger

Olivier is an accomplished antibody engineer with more than 30-year experience having worked for biotech (MRC collaborative centre and NovImmune) and pharma companies (Pierre Fabre, Merck Serono and Vetoquinol). Co-inventor of three marketed therapeutic antibodies, Tysarbri, Bavencio and Gamifant. Co-founder of the technology company Deeptope. Olivier has expertise in antibody development from discovery to lead optimization ready to enter pre-clinical studies. Olivier has been working as an independent consultant for the past 8 years. He holds a PhD in Molecular Immunology from the University of London in 1989.